After two years, did Viagra live up to its expectations?
Srinivas Madduri
Abstract
Srinivas Madduri
Abstract
Sildenafil (Viagra) is the first on-demand oral medication approved for treatment of male erectile dysfunction (ED). Since the unprecedented release of sildenafil, the initial surge of 'Viagra craze' has subsided and there is a considerable decline in world-wide prescriptions. We did a long-term efficacy study of sildenafil in our community practice to assess the discontinuation rate and the etiologic factors causing discontinuation.
OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Sildenafil (Viagra) is the first on-demand oral medication approved for treatment of male erectile dysfunction (ED). Since the unprecedented release of sildenafil, the initial surge of 'Viagra craze' has subsided and there is a considerable decline in world-wide prescriptions. We did a long-term efficacy study of sildenafil in our community practice to assess the discontinuation rate and the etiologic factors causing discontinuation.
Key concepts: Discontinuation, Sildenafil, Erectile dysfunction, Medicine, Medical prescription, Intensive care medicine, Internal medicine, Pharmacology